Alteration of Thyroid Hormone Homeostasis by Antiepileptic Drugs in Humans: Involvement of Glucuronosyltransferase Induction

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 2005 Nov 25

PMID 16307266

Citations 14

Authors

M Strolin Benedetti

R Whomsley

E Baltes

F Tonner

Affiliations

Soon will be listed here.

Abstract

Rationale: The aim of this review article is to analyse which antiepileptic drugs (AEDs) alter thyroid hormone homeostasis in humans and when this can be explained, at least partially, by the induction of the glucuronoconjugation pathways.

Methods: Electronic databases were searched which have provided more than 300 articles. These have been integrated with fundamental books and personal information by experts in the different areas examined.

Results: Alteration of thyroid hormone homeostasis by phenobarbital/primidone, phenytoin, and carbamazepine clearly occurs in humans. However, it is not associated with thyroid-stimulating hormone (TSH) increase and the clinical significance of altered serum concentrations of thyroid hormones by these antiepileptic drugs has remained unclear. The published information on the effect of the other antiepileptic drugs examined in this review article on thyroid hormones is lacking (felbamate, pregabalin, zonisamide) or limited. Oxcarbazepine appears to have some effects. Topiramate would need further investigations as well as gabapentin. Levetiracetam, tiagabine, vigabatrine, and lamotrigine do not alter at all, or only minimally, thyroid hormone homeostasis.

Conclusion: Concerning the antiepileptic drugs which alter thyroid hormone homeostasis, it is highly probable that the mechanism of induction of uridine diphosphate glucuronosyltransferases (UGT) is involved, at least partially, in such an alteration. However, it is not possible to estimate the relative contribution of the UGT induction by these drugs on the total alteration observed in thyroid hormone levels, as other mechanisms not investigated, or not examined in the present article, could contribute.

Citing Articles

Thyroid Hormone Levels in Preterm Neonates with Birth Weight Less than 2500 g, Treated with Phenobarbital.

Bidabadi E, Zarkesh M, Mirzaiichaghakabudi M Iran J Child Neurol. 2023; 17(4):155-162.

PMID: 38074926 PMC: 10704285. DOI: 10.22037/ijcn.v17i4.42583.

Gene polymorphisms and thyroid hormone signaling: implication for the treatment of hypothyroidism.

Penna G, Salas-Lucia F, Ribeiro M, Bianco A Endocrine. 2023; 84(2):309-319.

PMID: 37740833 PMC: 10959761. DOI: 10.1007/s12020-023-03528-y.

Influence of medications on thyroid function in dogs: An update.

Bolton T, Panciera D J Vet Intern Med. 2023; 37(5):1626-1640.

PMID: 37498128 PMC: 10473007. DOI: 10.1111/jvim.16823.

Carbamazepine drug effect simulating biochemical central hypothyroidism in a patient with Bardet-Biedl syndrome.

Kishlyansky D, Kline G BMJ Case Rep. 2021; 14(9).

PMID: 34479901 PMC: 8420699. DOI: 10.1136/bcr-2021-245018.

Subclinical hypothyroidism in children: updates for pediatricians.

Metwalley K, Farghaly H Ann Pediatr Endocrinol Metab. 2021; 26(2):80-85.

PMID: 34218629 PMC: 8255859. DOI: 10.6065/apem.2040242.121.

References

Vainionpaa L, Mikkonen K, Rattya J, Knip M, Pakarinen A, Myllyla V . Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia. 2004; 45(3):197-203. DOI: 10.1111/j.0013-9580.2004.26003.x. View

Kato Y, Suzuki H, Ikushiro S, Yamada S, Degawa M . Decrease in serum thyroxine level by phenobarbital in rats is not necessarily dependent on increase in hepatic UDP-glucuronosyltransferase. Drug Metab Dispos. 2005; 33(11):1608-12. DOI: 10.1124/dmd.105.005744. View

Frye M, Luckenbaugh D, Kimbrell T, Constantino C, Grothe D, Cora-Locatelli G . Possible gabapentin-induced thyroiditis. J Clin Psychopharmacol. 1999; 19(1):94-5. DOI: 10.1097/00004714-199902000-00015. View

Findlay K, Kaptein E, Visser T, Burchell B . Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab. 2000; 85(8):2879-83. DOI: 10.1210/jcem.85.8.6715. View

Spina E, Pisani F, Perucca E . Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet. 1996; 31(3):198-214. DOI: 10.2165/00003088-199631030-00004. View

Capen C . Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol. 1997; 25(1):39-48. DOI: 10.1177/019262339702500109. View

Bock K . Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers. Biochem Pharmacol. 1987; 36(23):4137-43. DOI: 10.1016/0006-2952(87)90572-7. View

Liewendahl K, Majuri H, Helenius T . Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs. Clin Endocrinol (Oxf). 1978; 8(3):185-91. DOI: 10.1111/j.1365-2265.1978.tb01493.x. View

Connell J, Rapeport W, Gordon S, Brodie M . Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. Eur J Clin Pharmacol. 1984; 26(4):453-6. DOI: 10.1007/BF00542140. View

10.

Li A, Hartman N, Lu C, Collins J, Strong J . Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes. Br J Clin Pharmacol. 1999; 48(5):733-42. PMC: 2014360. DOI: 10.1046/j.1365-2125.1999.00081.x. View

11.

Aanderud S, Strandjord R . Hypothyroidism induced by anti-epileptic therapy. Acta Neurol Scand. 1980; 61(5):330-2. DOI: 10.1111/j.1600-0404.1980.tb01501.x. View

12.

Hood A, Klaassen C . Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues. Toxicol Appl Pharmacol. 2000; 163(3):240-8. DOI: 10.1006/taap.1999.8883. View

13.

Anderson G . A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998; 32(5):554-63. DOI: 10.1345/aph.17332. View

14.

Visser T . Role of sulfation in thyroid hormone metabolism. Chem Biol Interact. 1994; 92(1-3):293-303. DOI: 10.1016/0009-2797(94)90071-x. View

15.

Isojarvi J, Airaksinen K, Mustonen J, Pakarinen A, Rautio A, Pelkonen O . Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. Epilepsia. 1995; 36(8):810-6. DOI: 10.1111/j.1528-1157.1995.tb01619.x. View

16.

Chin W, SCHUSSLER G . Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin. J Clin Endocrinol Metab. 1968; 28(2):181-6. DOI: 10.1210/jcem-28-2-181. View

17.

Liewendahl K, Helenius T, Majuri H, Ebeling P, Ahlfors U . Effect of anticonvulsant and antidepressant drugs on iodothyronines in serum. Scand J Clin Lab Invest. 1980; 40(8):767-74. DOI: 10.3109/00365518009095594. View

18.

Ben-Menachem E, Axelsen M, Johanson E, Stagge A, Smith U . Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res. 2003; 11(4):556-62. DOI: 10.1038/oby.2003.78. View

19.

Scott A, Khir A, Steele W, Hawksworth G, Petrie J . Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with phenobarbitone. Br J Clin Pharmacol. 1983; 16(4):441-4. PMC: 1428032. DOI: 10.1111/j.1365-2125.1983.tb02193.x. View

20.

Isojarvi J, Turkka J, Pakarinen A, Kotila M, Rattya J, Myllyla V . Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia. 2001; 42(7):930-4. DOI: 10.1046/j.1528-1157.2001.042007930.x. View